The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Open accessAbstract
Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of TACE for HCC. TACE can be performed using two techniques; conventional TACE (cTACE) and drug-eluting beads using TACE (DEB-TACE). The anti-tumor effect of the two has been reported to be similar; however, DEB-TACE carries a higher risk of hepatic artery and biliary injuries and a relatively lower risk of post-procedural pain than cTACE. TACE can be used for early stage HCC if other curative treatments are not feasible or as a neoadjuvant treatment before liver transplantation. TACE can also be considered for selected patients with limited portal vein thrombosis and preserved liver function. When deciding to repeat TACE, the ART (Assessment for Retreatment with TACE) score and ABCR (AFP, BCLC, Child-Pugh, and Response) score can guide the decision process, and TACE refractoriness needs to be considered. Studies on the combination therapy of TACE with other treatment modalities, such as local ablation, radiation therapy, or systemic therapy, have been actively conducted and are still ongoing. Recently, new prognostic models, including analysis of the neutrophil-lymphocyte ratio, radiomics, and deep learning, have been developed to help predict survival after TACE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097 · cited 1×
“Sorafenib is the treatment of choice for advanced HCC, and lenvatinib has also been recommended as a first-line systemic treatment after its non-inferiority to sorafenib was demonstrated [40,41].”
BackgroundEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Radiomics: Images Are More than Pictures, They Are Data
Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016) · Radiology · doi:10.1148/radiol.2015151169 · Cited by 8,421
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Radiomics: extracting more information from medical images using advanced feature analysis
Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Park, J., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P., Kudo, M., Johnson, P., Wagner, S., Orsini, L. S., et al. (2015) · Liver International · doi:10.1111/liv.12818 · Cited by 1,245
Omata, M., Lesmana, L. A., Tateishi, R., Chen, P.-J., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9165-7 · Cited by 1,026
Kudo, M., Izumi, N., Kokudo, N., Matsui, O., Sakamoto, M., Nakashima, O., Kojiro, M., Makuuchi, M., & for the HCC Expert Panel of Japan Society of Hepatology (2011) · Digestive Diseases · doi:10.1159/000327577 · Cited by 825
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Duffy, A. G., Ulahannan, S. V., Makorova-Rusher, O., Rahma, O., Wedemeyer, H., Pratt, D., Davis, J. L., Hughes, M. S., Heller, T., ElGindi, M., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.029 · Cited by 819
Lencioni, R., de Baere, T., Soulen, M. C., Rilling, W. S., & Geschwind, J. H. (2016) · Hepatology · doi:10.1002/hep.28453 · Cited by 732
Kudo, M., Ueshima, K., Ikeda, M., Torimura, T., Tanabe, N., Aikata, H., Izumi, N., Yamasaki, T., Nojiri, S., Hino, K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318934 · Cited by 721
Yau, T., Tang, V. Y. F., Yao, T.-J., Fan, S.-T., Lo, C.-M., & Poon, R. T. P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.032 · Cited by 698
Lencioni, R., Llovet, J. M., Han, G., Tak, W. Y., Yang, J., Guglielmi, A., Paik, S. W., Reig, M., Kim, D. Y., Chau, G.-Y., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.012 · Cited by 694
Burroughs, A., Dufour, J.-F., Galle, P., Mazzaferro, V., Piscaglia, F., Raoul, J., Sangro, B., & Bolondi, L. (2013) · Seminars in Liver Disease · doi:10.1055/s-0032-1329906 · Cited by 641
on behalf of the PRECISION ITALIA STUDY GROUP, Golfieri, R., Giampalma, E., Renzulli, M., Cioni, R., Bargellini, I., Bartolozzi, C., Breatta, A. D., Gandini, G., Nani, R., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.199 · Cited by 606
Neutrophils in the tumor microenvironment
Powell, D. R., & Huttenlocher, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.11.008 · Cited by 578
Peng, Z.-W., Zhang, Y.-J., Chen, M.-S., Xu, L., Liang, H.-H., Lin, X.-J., Guo, R.-P., Zhang, Y.-Q., & Lau, W. Y. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.9936 · Cited by 531
Meyer, T., Fox, R., Ma, Y. T., Ross, P. J., James, M. W., Sturgess, R., Stubbs, C., Stocken, D. D., Wall, L., Watkinson, A., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30156-5 · Cited by 499
Alifakioti, D., Daccord, C., Lachenal, Y., & Fitting, J.-W. (2014) · Respiration · doi:10.1159/000367814 · Cited by 495
Burrel, M., Reig, M., Forner, A., Barrufet, M., Lope, C. R. D., Tremosini, S., Ayuso, C., Llovet, J. M., Real, M. I., & Bruix, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.008 · Cited by 485
Treatment of intermediate-stage hepatocellular carcinoma
Forner, A., Gilabert, M., Bruix, J., & Raoul, J.-L. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.122 · Cited by 466
Ikai, I., Arii, S., Kojiro, M., Ichida, T., Makuuchi, M., Matsuyama, Y., Nakanuma, Y., Okita, K., Omata, M., Takayasu, K., et al. (2004) · Cancer · doi:10.1002/cncr.20426 · Cited by 451
Yoon, S. M., Ryoo, B.-Y., Lee, S. J., Kim, J. H., Shin, J. H., An, J. H., Lee, H. C., & Lim, Y.-S. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5847 · Cited by 446
Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors
Uchino, K., Tateishi, R., Shiina, S., Kanda, M., Masuzaki, R., Kondo, Y., Goto, T., Omata, M., Yoshida, H., & Koike, K. (2011) · Cancer · doi:10.1002/cncr.25960 · Cited by 427
Otto, G., Herber, S., Heise, M., Lohse, A. W., Mönch, C., Bittinger, F., Hoppe-Lotichius, M., Schuchmann, M., Victor, A., & Pitton, M. (2006) · Liver Transplantation · doi:10.1002/lt.20837 · Cited by 410
Cucchetti, A., Piscaglia, F., Cescon, M., Colecchia, A., Ercolani, G., Bolondi, L., & Pinna, A. D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.009 · Cited by 407
Kadalayil, L., Benini, R., Pallan, L., O'Beirne, J., Marelli, L., Yu, D., Hackshaw, A., Fox, R., Johnson, P., Burroughs, A. K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt247 · Cited by 370
Kudo, M., Han, G., Finn, R. S., Poon, R. T. P., Blanc, J.-F., Yan, L., Yang, J., Lu, L., Tak, W.-Y., Yu, X., et al. (2014) · Hepatology · doi:10.1002/hep.27290 · Cited by 355
Sieghart, W., Hucke, F., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl, H., Trauner, M., & Peck-Radosavljevic, M. (2013) · Hepatology · doi:10.1002/hep.26256 · Cited by 343
Luo, J., Guo, R.-P., Lai, E. C. H., Zhang, Y.-J., Lau, W. Y., Chen, M.-S., & Shi, M. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1321-8 · Cited by 328
Bolondi, L., Burroughs, A. K., Dufour, J.-F., Galle, P. R., Mazzaferro, V., Piscaglia, F., Raoul, J., & Sangro, B. (2012) · BORIS (University Library Bern) · Cited by 320
Stotz, M., Pichler, M., Absenger, G., Szkandera, J., Arminger, F., Schaberl-Moser, R., Samonigg, H., Stojakovic, T., & Gerger, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.785 · Cited by 310
Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Shi, J., Lai, E. C. H., Li, N., Guo, W.-X., Xue, J., Lau, W. Y., Wu, M.-C., & Cheng, S.-Q. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0940-4 · Cited by 287
Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
Kudo, M., Matsui, O., Izumi, N., Kadoya, M., Okusaka, T., Miyayama, S., Yamakado, K., Tsuchiya, K., Ueshima, K., Hiraoka, A., et al. (2014) · Oncology · doi:10.1159/000368142 · Cited by 283
Golfieri, R., Cappelli, A., Cucchetti, A., Piscaglia, F., Carpenzano, M., Peri, E., Ravaioli, M., D'Errico-Grigioni, A., Pinna, A. D., & Bolondi, L. (2011) · Hepatology · doi:10.1002/hep.24246 · Cited by 264
Wang, Q., Xia, D., Bai, W., Wang, E., Sun, J., Huang, M., Mu, W., Yin, G., Li, H., Zhao, H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.013 · Cited by 261
Millonig, G., Graziadei, I. W., Freund, M. C., Jaschke, W. R., Stadlmann, S., Ladurner, R., Margreiter, R., & Vogel, W. (2007) · Liver Transplantation · doi:10.1002/lt.21033 · Cited by 257
Huo, Y. R., & Eslick, G. D. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2189 · Cited by 238
Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
Xiao, W.-K., Chen, D., Li, S.-Q., Fu, S.-J., Peng, B.-G., & Liang, L.-J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-117 · Cited by 231
Yoon, S. M., Lim, Y.-S., Won, H. J., Kim, J. H., Kim, K. M., Lee, H. C., Chung, Y.-H., Lee, Y. S., Lee, S. G., Park, J.-H., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.03.019 · Cited by 223
Leijenaar, R. T. H., Carvalho, S., Hoebers, F. J. P., Aerts, H. J. W. L., van Elmpt, W. J. C., Huang, S. H., Chan, B., Waldron, J. N., O’sullivan, B., & Lambin, P. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1061214 · Cited by 217
Facciorusso, A., Di Maso, M., & Muscatiello, N. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.02.005 · Cited by 209
Arizumi, T., Ueshima, K., Minami, T., Kono, M., Chishina, H., Takita, M., Kitai, S., Inoue, T., Yada, N., Hagiwara, S., et al. (2015) · Liver Cancer · doi:10.1159/000367743 · Cited by 207
Kudo, M., Cheng, A.-L., Park, J.-W., Park, J. H., Liang, P.-C., Hidaka, H., Izumi, N., Heo, J., Lee, Y. J., Sheen, I.-S., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30290-x · Cited by 199
Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials
Kudo, M. (2017) · Oncology · doi:10.1159/000451016 · Cited by 194
Guiu, B., Deschamps, F., Aho, S., Munck, F., Dromain, C., Boige, V., Malka, D., Leboulleux, S., Ducreux, M., Schlumberger, M., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.012 · Cited by 191
Ogasawara, S., Chiba, T., Ooka, Y., Kanogawa, N., Motoyama, T., Suzuki, E., Tawada, A., Kanai, F., Yoshikawa, M., & Yokosuka, O. (2014) · Oncology · doi:10.1159/000365993 · Cited by 180
di Ruffano, L. F., Takwoingi, Y., Dinnes, J., Chuchu, N., Bayliss, S. E., Davenport, C. F., Matin, R., Godfrey, K., O'Sullivan, C., Gulati, A., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013186 · Cited by 180
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
Adhoute, X., Penaranda, G., Naude, S., Raoul, J. L., Perrier, H., Bayle, O., Monnet, O., Beaurain, P., Bazin, C., Pol, B., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.014 · Cited by 171
Hucke, F., Pinter, M., Graziadei, I., Bota, S., Vogel, W., Müller, C., Heinzl, H., Waneck, F., Trauner, M., Peck-Radosavljevic, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.002 · Cited by 159
Xue, T., Xie, X., Zhang, L., Yin, X. H., Zhang, B., & Ren, Z. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-60 · Cited by 156
Piscaglia, F., & Ogasawara, S. (2018) · Liver Cancer · doi:10.1159/000485471 · Cited by 151
How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
Raoul, J., Gilabert, M., & Piana, G. (2014) · Liver Cancer · doi:10.1159/000343867 · Cited by 150
Reig, M., Darnell, A., Forner, A., Rimola, J., Ayuso, C., & Bruix, J. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1394143 · Cited by 149
Bruix, J., Reig, M., Rimola, J., Forner, A., Burrel, M., Vilana, R., & Ayuso, C. (2010) · Hepatology · doi:10.1002/hep.24670 · Cited by 147
de Luna, W., Sze, D. Y., Ahmed, A., Ha, B., Ayoub, W. S., Keeffe, E. B., Cooper, A. D., Esquivel, C. O., & Nguyen, M. H. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02576.x · Cited by 146
Meng, M., Cui, Y., Lü, Y., She, B., Chen, Y., Guan, Y., & Zhang, R. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.11.002 · Cited by 143
Irie, T., Kuramochi, M., & Takahashi, N. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-012-0476-z · Cited by 142
Han, G., Berhane, S., Toyoda, H., Bettinger, D., Elshaarawy, O., Chan, A. W. H., Kirstein, M. M., Mosconi, C., Hucke, F., Palmer, D. H., et al. (2019) · Hepatology · doi:10.1002/hep.31022 · Cited by 142
Schobert, I. T., Savic, L. J., Chapiro, J., Bousabarah, K., Chen, E. M., Gaupp, F. M. L., Tefera, J., Nezami, N., Lin, M., Pollak, J. S., et al. (2020) · European Radiology · doi:10.1007/s00330-020-06931-5 · Cited by 127
Hucke, F., Sieghart, W., Pinter, M., Graziadei, I. W., Vogel, W., Müller, C., Heinzl, H., Waneck, F., Trauner, M., & Peck‐Radosavljevic, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.022 · Cited by 126
Kim, J., Choi, S. J., Lee, S.-H., Lee, H. Y., & Park, H. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.18.19507 · Cited by 123
Koo, J. E., Kim, J. H., Lim, Y., Park, S. J., Won, H. J., Sung, K., & Suh, D. J. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1730 · Cited by 111
Park, Y., Kim, S. U., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Park, Y. E., Park, J. H., Lee, Y. I., Yun, H., et al. (2015) · Liver International · doi:10.1111/liv.12878 · Cited by 108
Monier, A., Guiu, B., Durán, R., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4488-y · Cited by 107
Otto, G., Schuchmann, M., Hoppe‐Lotichius, M., Heise, M., Weinmann, A., Hansen, T., & Pitton, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.006 · Cited by 105
Tazawa, J., Maeda, M., Sakai, Y., Yamane, M., Ohbayashi, H., Kakinuma, S., Miyasaka, Y., Nagayama, K., Enomoto, N., & Sato, C. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02496.x · Cited by 100
Lee, I., Hung, Y., Liu, C., Lee, R., Su, C., Huo, T., Li, C., Chao, Y., Lin, H., Hou, M., et al. (2019) · Liver International · doi:10.1111/liv.14194 · Cited by 99
Cheung, T., Lai, C., Wong, B. C. Y., Fung, J., & Yuen, M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03029.x · Cited by 90
Zhao, J., Wozniak, A. L., Adams, A., Cox, J., Vittal, A., Voss, J. K., Bridges, B., Weinman, S. A., & Li, Z. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1246-4 · Cited by 89
Refining prognosis after trans‐arterial chemo‐embolization for hepatocellular carcinoma
Cappelli, A., Cucchetti, A., Cabibbo, G., Mosconi, C., Maida, M. F., Attardo, S., Pettinari, I., Pinna, A. D., & Golfieri, R. (2015) · Liver International · doi:10.1111/liv.13029 · Cited by 85
Kim, B. K., Shim, J. H., Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., Kim, K. M., Lim, Y., Han, K., & Lee, H. C. (2015) · Liver International · doi:10.1111/liv.12865 · Cited by 84
Spreafico, C., Cascella, T., Facciorusso, A., Sposito, C., Lanocita, R., Morosi, C., Civelli, E. M., Vaiani, M., Bhoori, S., Pellegrinelli, A., et al. (2014) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-014-0907-0 · Cited by 81
Radiomics of hepatocellular carcinoma
Lewis, S. C., Hectors, S. J. C. G., & Taouli, B. A. (2020) · Abdominal Radiology · doi:10.1007/s00261-019-02378-5 · Cited by 81
Chen, Q.-W., Ying, H.-F., Gao, S., Shen, Y.-H., Meng, Z.-Q., Chen, H., Chen, Z., & Teng, W.-J. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.07.008 · Cited by 79
Evaluation of liver tumour response by imaging
Grégory, J., Burgio, M. D., Corrias, G., Vilgrain, V., & Ronot, M. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100100 · Cited by 74
Santos, J. M. M. M., Oliveira, B. C., Araújo-Filho, J. D. A. B., Assunção, A. N., Machado, F. A. D. M., Rocha, C. C. T., Horvat, J. V., de Menezes, M. R., & Horvat, N. D. S. M. R. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02299-3 · Cited by 72
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials
Kudo, M. (2019) · Liver Cancer · doi:10.1159/000501501 · Cited by 71
Pinato, D. J., Arizumi, T., Allara, E., Jang, J. W., Smirne, C., Kim, Y. W., Kudo, M., Pirisi, M., & Sharma, R. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.037 · Cited by 68
Switching to systemic therapy after locoregional treatment failure: Definition and best timing
Ogasawara, S., Ooka, Y., Koroki, K., Maruta, S., Kanzaki, H., Kanayama, K., Kobayashi, K., Kiyono, S., Nakamura, M., Kanogawa, N., et al. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2019.0021n · Cited by 64
Terzi, E., Terenzi, L., Venerandi, L., Croci, L., Renzulli, M., Mosconi, C., Allegretti, G., Granito, A., Golfieri, R., Bolondi, L., et al. (2014) · Digestive Diseases · doi:10.1159/000368007 · Cited by 61
Kudo, M., & Arizumi, T. (2017) · Oncology · doi:10.1159/000481243 · Cited by 61
Blanc‐Durand, P., Gucht, A. V. D., Jreige, M., Lalonde, M. N., Silva-Monteiro, M., Prior, J. O., Denys, A. L., Depeursinge, A., & Schaefer, N. G. (2017) · Oncotarget · doi:10.18632/oncotarget.23423 · Cited by 60
Sun, Y., Bai, H., Xia, W., Wang, D., Zhou, B., Zhao, X.-Y., Yang, G.-W., Xu, L., Zhang, W., Liu, P., et al. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27143 · Cited by 60
Park, H. C., Yu, J. I., Cheng, J. C., et al. (2016) · Liver Cancer · doi:10.1159/000367766 · Cited by 59
Meng, X., Wang, Y., Ju, S., Lu, C., Zhong, B., Ni, C., Zhang, Q., Yu, Q., Xu, J., Ji, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01196 · Cited by 49
Kudo, M., Arizumi, T., & Ueshima, K. (2013) · Hepatology · doi:10.1002/hep.26760 · Cited by 39
Lee, J. S., Kim, B. K., Kim, S. U., Park, J. Y., Ahn, S. H., Seong, J. S., Han, K., & Kim, D. Y. (2019) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.0065 · Cited by 38
Zhou, D., Liang, J., Xu, L., He, F., Zhou, Z., Zhang, Y., & Chen, M. (2016) · Oncology Letters · doi:10.3892/ol.2016.4359 · Cited by 36
Arizumi, T., Ueshima, K., Iwanishi, M., et al. (2015) · Oncology · doi:10.1159/000440625 · Cited by 25
Aloia, T. A., Adam, R. A., Samuel, D., Azoulay, D., & Castaing, D. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0211-2 · Cited by 24
Xue, M., Wu, Y., Fan, W., Guo, J. M., Wei, J., Wang, H., Tan, J., Wang, Y., Yao, W., Zhao, Y., et al. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2019.533 · Cited by 22
Cited by
Liu, Z., Li, M., Jia, Y., Zheng, L., & Chen, L. (2025) · BMC Cancer · doi:10.1186/s12885-025-13679-y · Cited by 7
Metadata
- Authors
- Chang, Y., Jeong, S. W., Young Jang, J., & Jae Kim, Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-31
- Volume
- 21
- Issue
- 21
- Pages
- 8165
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3096663029
- Cited by
- 336
- References
- 113
- FWCI
- 16.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.